U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
184471184471Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate CancerRecruitingNo Results AvailableProstate CancerBiological: OGX-011https://ClinicalTrials.gov/show/NCT00138918
184472184472Experimental Study of Mobile Base Station Related Radio-Frequency Electromagnetic RadiationCompletedNo Results AvailableBehavior|Cognition DisordersDevice: UMTS mobile basestation radiationhttps://ClinicalTrials.gov/show/NCT00138905
184473184473A Randomized Controlled Trial of Long Versus Short Wait For Primary Total Hip and Knee ArthroplastyActive, not recruitingNo Results AvailableOsteoarthritisProcedure: Waiting time (access time to Total joint replacement)https://ClinicalTrials.gov/show/NCT00138892
184474184474Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease PatientsCompletedNo Results AvailableCrohn's Disease|Short Bowel Syndrome|Malabsorption Syndromes|Celiac Diseasehttps://ClinicalTrials.gov/show/NCT00138879
184475184475Risedronate for the Treatment of Osteoporosis for People With Spinal Cord InjuryCompletedNo Results AvailableOsteoporosisDrug: Risedronatehttps://ClinicalTrials.gov/show/NCT00138866
184476184476A Roentgen Stereophotogrammetric Analysis on Migration of Knee Prostheses.CompletedNo Results AvailableOsteoarthritisDevice: Tibial componenthttps://ClinicalTrials.gov/show/NCT00138853
184477184477Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: STA-5326 mesylatehttps://ClinicalTrials.gov/show/NCT00138840
184478184478Mouth Care Regimes During RadiotherapyCompletedNo Results AvailableHead and Neck NeoplasmsDrug: Biotene (mouth care)https://ClinicalTrials.gov/show/NCT00138827
184479184479Boost Use in Breast Conservation RadiotherapyRecruitingNo Results AvailableBreast NeoplasmsProcedure: Radiotherapy (boost versus no boost)https://ClinicalTrials.gov/show/NCT00138814
184480184480Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme NeuroborreliosisCompletedNo Results AvailableLyme NeuroborreliosisDrug: Ceftriaxone|Drug: Doxycyclinehttps://ClinicalTrials.gov/show/NCT00138801
184481184481Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain MetastasesCompletedNo Results AvailableNeoplasm Metastasis|Brain NeoplasmsProcedure: Radiotherapy, dose fractionationhttps://ClinicalTrials.gov/show/NCT00138788
184482184482Israel Multicenter D-Serine Study (IMSER) for the Treatment of SchizophreniaRecruitingNo Results AvailableSchizophrenia|Schizoaffective DisorderDrug: D-serinehttps://ClinicalTrials.gov/show/NCT00138775
184483184483A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High CholesterolCompletedNo Results AvailableHyperlipidemiaDrug: torcetrapib/atorvastatin|Drug: atorvastatin|Drug: placebohttps://ClinicalTrials.gov/show/NCT00138762
184484184484An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.CompletedNo Results AvailableUrinary Incontinence, StressDrug: SS-RBXhttps://ClinicalTrials.gov/show/NCT00138749
184485184485Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced NeutropeniaCompletedNo Results AvailableMBL-Deficient|NeutropeniaDrug: Mannan Binding Lectin (MBL)|Drug: Mannan Binding Lectinhttps://ClinicalTrials.gov/show/NCT00138736
184486184486Trial to Investigate the Efficacy, Tolerability and Safety of Fesoterodine Sustained Release in Subjects With Overactive Bladder SyndromeCompletedNo Results AvailableOveractive BladderDrug: SPM 907https://ClinicalTrials.gov/show/NCT00138723
184487184487Short-term Effects of Aromatase Inhibition in Obese MenCompletedNo Results AvailableHypogonadotrophic Hypogonadism|ObesityDrug: Letrozole (Femara)https://ClinicalTrials.gov/show/NCT00138710
184488184488Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia PatientsCompletedNo Results AvailableHypogammaglobulinemiaDrug: IVIG-Lhttps://ClinicalTrials.gov/show/NCT00138697
184489184489Cytochrome P450 2E1 and Iron OverloadCompletedNo Results AvailableInsulin Resistance|Iron OverloadProcedure: venesectionhttps://ClinicalTrials.gov/show/NCT00138684
184490184490A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With COPDTerminatedHas ResultsDiabetes Mellitus|Chronic Obstructive Pulmonary DiseaseDrug: Subcutaneous Insulin|Drug: Inhaled Insulinhttps://ClinicalTrials.gov/show/NCT00138671
184491184491A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)CompletedHas ResultsNon-small Cell Lung CancerDrug: custirsen sodiumhttps://ClinicalTrials.gov/show/NCT00138658
184492184492The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard DietCompletedHas ResultsBody Weight ChangesBehavioral: MicroDiet|Behavioral: Healthy Diethttps://ClinicalTrials.gov/show/NCT00138645
184493184493Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)CompletedNo Results AvailableWet Age-Related Macular DegenerationDrug: PTK787|Drug: PTK787|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00138632
184494184494Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00138619
184495184495Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00138606
184496184496Extension to a Study of the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes With Hemoglobin A1c (HbA1c) 9-11%CompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00138593
184497184497Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00138580
184498184498Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00138567
184499184499Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptin|Drug: pioglitazonehttps://ClinicalTrials.gov/show/NCT00138554
184500184500Extension to a Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: vildagliptinhttps://ClinicalTrials.gov/show/NCT00138541

* Görseller ve İçerik tekif hakkına sahip olabilir